45, X, 46, XY gonadal dysgenesis (Q84783): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Disgenesia gonadal mista 45,X/46,XY é um distúrbio do desenvolvimento sexual (DDS) associado a uma anormalidade numérica do cromossomo sexual resultante de mosaicismo do cromossomo Y e levando a desenvolvimento gonadal anormal. A prevalência é desconhecida. As manifestações clínicas são altamente variáveis, desde virilização parcial e genitália ambígua ao nascimento até pacientes com fenótipo completamente masculino ou feminino.
description / endescription / en
 
45,X/46,XY mixed gonadal dysgenesis is a disorder of sex development (DSD) associated with a numerical sex chromosome abnormality resulting from Y-chromosome mosaicism and leading to abnormal gonadal development. Prevalence is unknown. The clinical manifestations are highly variable, ranging from partial virilization and ambiguous genitalia at birth to patients with a completely male or female phenotype.

Revision as of 10:08, 15 August 2026

45,X/46,XY mixed gonadal dysgenesis is a disorder of sex development (DSD) associated with a numerical sex chromosome abnormality resulting from Y-chromosome mosaicism and leading to abnormal gonadal development. Prevalence is unknown. The clinical manifestations are highly variable, ranging from partial virilization and ambiguous genitalia at birth to patients with a completely male or female phenotype.
Language Label Description Also known as
default for all languages
ID_451241641
    English
    45, X, 46, XY gonadal dysgenesis
    45,X/46,XY mixed gonadal dysgenesis is a disorder of sex development (DSD) associated with a numerical sex chromosome abnormality resulting from Y-chromosome mosaicism and leading to abnormal gonadal development. Prevalence is unknown. The clinical manifestations are highly variable, ranging from partial virilization and ambiguous genitalia at birth to patients with a completely male or female phenotype.

      Statements